TrialEuropean heart journal2021

The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context.

John J V McMurray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.